Blog

Gut Bacteria Composition May Determine Melanoma Patients’ Response to Anti-PD-1 Immunotherapy – Melanoma News Today


Melanoma News Today

Gut Bacteria Composition May Determine Melanoma Patients' Response to Anti-PD-1 Immunotherapy
Melanoma News Today
The presence of a specific bacteria in the gut of patients with melanoma, as well as a greater diversity of gut bacteria, are associated with a better response to anti-PD-1 immunotherapy. Understanding this relationship between a patient's gut bacteria

2017-02-28 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.